Charles River to Acquire Cellero
This acquisition will strengthen our ability to help accelerate critical programs for cell therapy developers and manufacturers worldwide.
Our donor center operations have resumed. See the additional steps we are taking to ensure the safety of everyone involved. READ MORE
HemaCare Solutions
At HemaCare, Quality Comes First
HemaCare maintains the highest regulatory compliance in the industry. Setting the Standard
News and Events
-
Charles River to Acquire CelleroAcquisition will strengthen our ability to help accelerate critical programs for cell therapy developers and manufacturers worldwide.READ MORE
-
HemaCare Adds GMPrimeTM Cryopreserved Leukopak to its GMP Product PortfolioREAD MORE
-
HemaCare Expands Its Product Portfolio with GMPrimeTM Bone Marrow AspirateAdvancing cell and gene therapies with the highest quality GMP-compliant bone marrow starting materialREAD MORE
Interested
Sign up for our newsletter for updates on events, news, and blog posts